The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
The trial enrolled patients with stage IV pancreatic cancer, where median life expectancy is just 6 to 12 months
The protections extend through at least 2035, with the potential for further extensions
Under the deal, Vivtex will license select oral drug-delivery technologies to Novo Nordisk
The program offers selected participants advanced access to Promise Bio’s broad-epiproteomic platform
Subscribe To Our Newsletter & Stay Updated
